SpecGx to Offer Covered Entities Refunds for a Record 30-Plus Years of 340B Overcharges

Mallinckrodt's subsidiary, SpecGx, will offer refunds to covered entities for over 30 years of overcharges.
SpecGx, a generic subsidiary of Mallinckrodt Pharmaceuticals, will refund 340B covered entities that purchased addiction treatment medication Methadose for above [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

HHS Submits 340B Rebate Guidance for Review, But Publication Timeline Remains Unclear

HHS submitted its 340B rebate guidance for regulatory review with OMB on June 1.
The Department of Health and Human Services (HHS) has submitted proposed 340B rebate guidance for regulatory review—but it is unclear [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Breaking News

Trump’s Full 2026 Budget Request Would Shift 340B Program from HRSA to CMS, Maintain Current OPA Funding

CMS would assume oversight of the 340B program under the White House’s full fiscal year 2026 budget proposal released May 30.
President Donald Trump’s fiscal year 2026 budget request released yesterday calls for moving control of the 340B program away from [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

First 340B Administrative Dispute Resolution Panel Decision Sides with Drug Industry

The first decision was recently issued under HRSA's revised 340B Administrative Dispute Resolution process.
The first published decision under the revamped 340B Administrative Dispute Resolution (ADR) process sided with the drug industry, marking a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Novo Nordisk, Merck, GSK to Refund 340B Covered Entities for Overcharges

Novo Nordisk, Merck and GSK announced they will refund covered entities following certain overcharges for 340B drugs.
Three drugmakers will refund covered entities that purchased certain 340B-priced medications following recent adjustments to their 340B drug ceiling prices. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HRSA Defends 340B Hospital Drug Purchasing Restrictions Policy, Asks Federal Court to Reject Premier’s Challenge

HHS attorneys recently urged a Washington D.C. federal court to uphold a 2013 HRSA policy and reject Premier's claim that it unlawfully restricts how certain 340B hospitals can purchase initial drug inventory.
The Trump administration this month urged a Washington D.C. federal court to uphold a 2013 Health Resources and Services Administration [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Providers Applaud Federal Judge’s 340B Rebate Ruling as Drugmakers Mull Next Steps

340B stakeholders are reacting to U.S District Judge Dabney Friedrich's May 15 ruling on a series of controversial drugmaker 340B rebate lawsuits.
A federal judge’s decision to uphold the government’s authority to pre-approve drugmaker 340B rebate models has drawn praise from providers, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Viatris, Amgen, GSK Announce 340B Refunds; Amgen Issues NDC Change

Viatris and two other drugmakers recently issued notices to 340B covered entities.
Three drugmakers recently announced refunds for 340B covered entities that were overcharged when buying certain drugs. Viatris, Amgen and GSK [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Breaking News

Federal Judge Upholds HHS’ Right to Pre-Approve 340B Rebates, Tosses Four of Five Drugmaker Lawsuits

Judge Dabney Friedrich of the U.S. District Court for the District of Columbia largely sided with HHS and against the drug industry in multiple 340B rebate lawsuits.
A federal district judge has upheld the federal government’s authority to require agency approval of drugmaker 340B rebate models, dealing [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Breaking News

HHS Secretary RFK Jr. Weighs in on 340B Program Publicly for 1st Time

HHS Secretary. Robert F. Kennedy Jr. told House lawmakers Wednesday that he could not confirm reports that HHS is seeking to shift 340B to CMS due to a “court order."
Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. provided his first public remarks on the 340B program Wednesday [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live